The Exchange had sought clarification from Dr Reddys Laboratories with respect to news appearing on Business Standard on August 21, 2015 titled ‘DRL recalls dementia capsules in US’. Dr Reddys Laboratories replied stating that in this regard, they would like to state that Dr. Reddys have recalled one batch of USP 1.5mg Rivastigmine Tartarate capsule from US market. This is a batch specific voluntary recall in conformance with our quality assurance norms practiced. The business impact from this will not be substantial.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1908.35 |
| Dr. Reddys Labs. | 1379.35 |
| Cipla | 1464.80 |
| Zydus Lifesciences | 1130.00 |
| Lupin | 2470.05 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: